Prescription History / Anti-Seizure Medication
Anti-Seizure Medication: underwriting considerations
e.g., Keppra, Dilantin, Lamictal
Typically interpreted as an indicator of an epilepsy or seizure history rather than as an independent concern.
Carriers attach less significance to the medication itself than to what it indicates: the duration of seizure-free status, and whether the underlying condition is controlled. An extended period without a seizure while maintained on a stable dose commonly qualifies for level coverage. A recent seizure, or a recent adjustment to the medication regimen, is more likely to prompt additional underwriting questions or a graded classification.
Material considerations
Carriers establish independent criteria for evaluating any given prescription, such that identical medications may be treated differently across carriers. Health and medication questions should be answered accurately in all cases — the carrier verifies prescription history independent of disclosure, and any discrepancy may jeopardize a future claim.